Sarcoma Information Center
Knowledge is power. Are you facing a new diagnosis, recurrence, living with metastatic disease, or supporting a loved one through their cancer journey? The Cancer Connect sarcoma Information Center has current, evidence-based information for you. Get the facts about sarcoma , early detection, treatment, and survivorship, and stay up to date with ongoing sarcoma research that could impact your treatment decisions through our daily cancer news.
You are not alone—The CancerConnect Sarcoma Community is the leading Social Media Application for Sarcoma patients and caregivers seeking information, inspiration, and support in the wake of a cancer diagnosis. With over 50,000 members the network offers patients and caregivers a thriving community to support the many ongoing needs from diagnosis to survivorship. Login or register here.
YONDELIS® is a novel, multimodal, synthetically produced antitumor agent, originally derived from the sea squirt OMNI-Connect Gets National Recognition as Valuable Social Media Solution in Medicine
Fort Worth TX/Sun Valley ID – OMNI Health Media announces national recognition... Torisel Improves Event-Free Survival in Rhabdomyosarcoma Patients
In a study presented at the 2014 ASCO® meeting, researchers reported that Torisel® added to a chemotherapy regimen improved event-free survival in young rhabdomyosarcoma patients.
Cancer and its treatment can come with a variety of complications, some more serious... Advanced Directives
Living Wills Every competent adult has, in most cases, the freedom to accept or refuse... Caregivers
What is Caregiving and Who are Caregivers? Caregivers are individuals who provide...
Sean Swarner is a master of setting a goal and achieving it. So when he... Jack & Jill Late Stage Cancer Foundation
Jon Albert, founder of the Jack & Jill Late Stage Cancer Foundation shows the... Moving Bodies, Changing Lives
Moving On Aerobics helps women regain joy of movement and physical fitness after...
Sarcoma Clinical Trials
AP23573-07-302 – Pivotal Trial to Determine the Efficacy and Safety of AP23573 when Administered as Maintenance Therapy to Patients with Metastatic Soft-Tissue or Bone Sarcomas
COGAEWS07B1 – A COG Study for Collecting and Banking Ewing Sarcoma Specimens
ET743-SAR-3002 – A multicenter, open-label single-arm study of YONDELIS (trabectedin) for subjects with locally advanced or metastatic soft tissue sarcoma who have relapsed or are refractory to standard of care treatment.